Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 285, Issue 6 48-6, 2003, Pages

  Ramsanahie, Anthony ^a   Duxbury, Mark S ^a   Grikscheit, Tracy C ^a   Perez, Alexander ^a   Rhoads, David B ^a   Gardner Thorpe, James ^a   Ogilvie, Jennifer ^a   Ashley, Stanley W ^a   Vacanti, Joseph P ^a   Whang, Edward E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Glucagon like peptide 2; Neomucosa; Sodium glucose cotransporter 1; Tissue engineering

Indexed keywords

COTRANSPORTER; GLUCAGON LIKE PEPTIDE 2; MESSENGER RNA; SODIUM GLUCOSE COTRANSPORTER 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRUSH BORDER; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; INTESTINE; INTESTINE CELL; INTESTINE EPITHELIUM; INTESTINE VILLUS; MALE; NEWBORN; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; TISSUE ENGINEERING;

EID: 17544387543     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00374.2002     Document Type: Article

References (38)

1. Babensee JE, McIntire LV, and Mikos AG. Growth factor delivery for tissue engineering. Pharm Res 17: 497-504, 2000.
2. Bello YM, Falabella AF, and Eaglstein WH. Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol 2: 305-313, 2000.
3. Berger UV and Hediger MA. Differential distribution of the glutamate transporters GLT-1 and GLAST in tanycytes of the third ventricle. J Comp Neurol 433: 101-114, 2001.
4. Bjerknes M and Cheng H. Modulation of specific intestinal epithelial progenitors by enteric neurons. Proc Natl Acad Sci USA 98: 12497-12502, 2001.
5. Brubaker PL, Izzo A, Hill M, and Drucker DJ. Intestinal function in mice with small bowel growth induced by glucagon-like peptide 2. Am J Physiol Endocrinol Metab 272: E1050-E1058, 1997.
6. Burant CF, Flint S, DePaoli AM, Chen J, Lee WS, Hediger MA, Buse JB, and Chang EB. Small intestine hexose transport in experimental diabetes. J Clin Invest 93: 578-585, 1994.
7. Cheeseman CI. Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am J Physiol Regul Integr Comp Physiol 273: R1965-R1971, 1997.
8. Choi RS, Riegler M, Pothoulakis C, Kim BS, Mooney D, Vacanti M, and Vacanti JP. Studies of brush border enzymes, basement membrane components, and electrophysiology of tissue-engineered neointestine. J Pediatr Surg 33: 991-996, 1998.
9. Choi RS and Vacanti JP. Preliminary studies of tissue-engineered intestine using isolated epithelial organoid units on tubular synthetic biogradable scaffolds. Trans Proc 848-851, 1997.
10. Corpe CP and Burant CF. Hexose transporter expression in rat small intestine: effect of diet on diurnal variations. Am J Physiol Gastrointest Liver Physiol 271: G211-G216, 1996.
11. Drucker DJ. Glucagon-like peptide 2. J Clin Endocrinol Metab 86: 1759-1764, 2001.
12. Ercolani L, Florence B, Denaro M, and Alexander M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 263: 15335-15341, 1988.
13. Ferraris RP. Dietary and developmental regulation of intestinal sugar transport. Biochem J 360: 265-276, 2001.
14. Griffith LG and Naughton G. Tissue engineering-current challenges and expanding opportunities. Science 295: 1009-1014, 2002.
15. Grikscheit TC and Vacanti JP. The history and current status of tissue engineering: the future of pediatric surgery. J Pediatr Surg 37: 277-288, 2002.
16. Hartmann B, Thulesen J, Kissow H, Thulesen S, Orskov C, Ropke C, Poulsen SS, and Holst JJ. Dipeptidyl peptidase IV. Inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice. Endocrinology 141: 4013-4020, 2000.
17. +/glucose cotransporter and mRNA along the crypt-villus axis of rabbit small intestine. Biochem Biophys Res Commun 181: 1208-1217, 1991.
18. Jasleen J, Shimoda N, Shen ER, Tavakkolizadeh A, Whang EE, Jacobs DO, Zinner MJ, and Ashley SW. Signaling mechanisms of glucagon-like peptide 2-induced intestinal epithelial cell proliferation. J Surg Res 90: 13-18, 2000.
19. Kim SS, Kaihara S, Benvenuto MS, Choi RS, Kim BS, Mooney DJ, Taylor GA, and Vacanti JP. Regenerative signals for intestinal epithelial organoid units transplanted on biodegradable polymer scaffolds for tissue engineering of small intestine. Transplantation 67: 227-233, 1999.
20. Langer R and Vacanti JP. Tissue engineering. Science 260: 920-926, 1993.
21. +/glucose cotransporter. Re-evaluation of function and distribution of expression. J Biol Chem 269: 12032-12039, 1994.
22. Lovshin J, Estall J, Yusta B, Brown T, and Drucker DJ. Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling. J Biol Chem 276: 21489-21499, 2001.
23. Lovshin J, Yusta B, Iliopoulos I, Migirdicyan A, Dableh L, Brubaker PL, and Drucker DJ. Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine. Endocrinology 141: 4194-4201, 2000.
24. Mooney DJ, Mazzoni CL, Breuer C, McNamara K, Hern D, Vacanti JP, and Langer R. Stabilized polyglycolic acid fibre-based tubes for tissue engineering. Biomaterials 17: 115-124, 1996.
25. Murphy WL, Peters MC, Kohn DH, and Mooney DJ. Sustained release of vascular endothelial growth factor from mineralized poly (lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 21: 2521-2527, 2000.
26. Perez A, Grikscheit TC, Blumberg RS, Ashley SW, Vacanti JP, and Whang EE. Tissue-engineered small intestine: ontogeny of the immune system. Transplantation 74: 619-623, 2002.
27. Richardson TP, Peters MC, Ennett AB, and Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol 19: 1029-1034, 2001.
28. Rhoads DB, Rosenbaum DH, Unsal H, Isselbacher KJ, and Levitsky LL. Circadian periodicity of intestinal Na/glucose cotransporter 1 mRNA levels is transcriptionally regulated. J Biol Chem 273: 9510-9516, 1998.
29. Scott RB, Kirk D, MacNaughton WK, and Meddings JB. GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol Gastrointest Liver Physiol 275: G911-G921, 1998.
30. Sheridan MH, Shea LD, Peters MC, and Mooney DJ. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release 64: 91-102, 2000.
31. Shinoka T and Imai Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 344: 532-533, 2001.
32. Tavakkolizadeh A, Ashley SW, Vacanti JP, and Whang E. Tissue-engineered intestine: progress toward a functional and physiological neomucosa. Transplantation Rev 15: 178-183, 2001.
33. max, and mRNA expression topography. Am J Physiol Gastrointest Liver Physiol 280: G209-G215, 2001.
34. Tavakkolizadeh A, Berger UV, Stephen A, Kim B, Mooney D, Hediger MA, Ashley S, Vacanti J, and Whang E. Tissue-engineered neomucosa: morphology, enterocyte dynamics, and SGLT1 expression topography. Transplantation 75: 181-185, 2003.
35. Tavakkolizadeh A, Stephen A, Kaihara S, Mooney D, Kim B, Ashley S, Vacanti J, and Whang E. Topography of epithelial proliferation and apoptosis in the tissue-engineered intestine (Abstract). Surg Forum 51: 59, 2000.
36. Tsai CH, Hill M, Asa SL, Brubaker PL, and Drucker DJ. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol Endocrinol Metab 273: E77-E84, 1997.
37. Tsai CH, Hill M, and Drucker DJ. Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am J Physiol Gastrointest Liver Physiol 272: G662-G668, 1997.
38. Yusta B, Huang L, Munroe D, Wolff G, Fantaske R, Sharma S, Demchyshyn L, Asa SL, and Drucker DJ. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology 119: 744-755, 2000.